SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-006132
Filing Date
2015-08-05
Accepted
2015-08-05 06:30:58
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-10q_20150630.htm 10-Q 1219920
2 EX-31.1 nerv-ex311_201506309.htm EX-31.1 14142
3 EX-31.2 nerv-ex312_201506306.htm EX-31.2 13938
4 EX-32.1 nerv-ex321_201506308.htm EX-32.1 9739
  Complete submission text file 0001564590-15-006132.txt   4744335

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nerv-20150630.xml EX-101.INS 746587
6 XBRL TAXONOMY EXTENSION SCHEMA nerv-20150630.xsd EX-101.SCH 45560
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20150630_cal.xml EX-101.CAL 48962
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20150630_def.xml EX-101.DEF 177009
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20150630_lab.xml EX-101.LAB 357054
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20150630_pre.xml EX-101.PRE 305512
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 151027409
SIC: 2834 Pharmaceutical Preparations